BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23485505)

  • 1. Five-year experience with metallic stents for chronic ureteral obstruction.
    Kadlec AO; Ellimoottil CS; Greco KA; Turk TM
    J Urol; 2013 Sep; 190(3):937-41. PubMed ID: 23485505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of resonance metallic stents for ureteral obstruction.
    Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
    BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-institution experience with metallic ureteral stents: a cost-effective method of managing deficiencies in ureteral drainage.
    Baumgarten AS; Hakky TS; Carrion RE; Lockhart JL; Spiess PE
    Int Braz J Urol; 2014; 40(2):225-31. PubMed ID: 24856490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of metallic stents for malignant ureteral obstruction.
    Goldsmith ZG; Wang AJ; Bañez LL; Lipkin ME; Ferrandino MN; Preminger GM; Inman BA
    J Urol; 2012 Sep; 188(3):851-5. PubMed ID: 22819410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
    Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
    J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureteral obstruction: is the full metallic double-pigtail stent the way to go?
    Liatsikos E; Kallidonis P; Kyriazis I; Constantinidis C; Hendlin K; Stolzenburg JU; Karnabatidis D; Siablis D
    Eur Urol; 2010 Mar; 57(3):480-6. PubMed ID: 19232816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
    Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
    PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallic ureteral stents: a cost-effective method of managing benign upper tract obstruction.
    López-Huertas HL; Polcari AJ; Acosta-Miranda A; Turk TM
    J Endourol; 2010 Mar; 24(3):483-5. PubMed ID: 20210650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel second stent placement for refractory ureteral stent malfunction in malignant ureteral obstruction.
    Chen HC; Shen SH; Wang JH; Huang WJ; Tseng HS; Chang PY; Chang CY
    J Vasc Interv Radiol; 2011 Jul; 22(7):1012-6. PubMed ID: 21571544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.
    Modi AP; Ritch CR; Arend D; Walsh RM; Ordonez M; Landman J; Gupta M; Knudsen BE
    J Endourol; 2010 Jul; 24(7):1189-93. PubMed ID: 20575695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
    Izumi K; Mizokami A; Maeda Y; Koh E; Namiki M
    J Urol; 2011 Feb; 185(2):556-61. PubMed ID: 21168872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
    Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
    Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and revision efficacy of cross-wired metallic stents for endoscopic bilateral stent-in-stent placement in malignant hilar biliary strictures.
    Lee TH; Moon JH; Kim JH; Park DH; Lee SS; Choi HJ; Cho YD; Park SH; Kim SJ
    Endoscopy; 2013; 45(2):106-13. PubMed ID: 23212727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
    Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
    Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion.
    Chung HH; Kim MD; Won JY; Won JH; Cho SB; Seo TS; Park SW; Kang BC
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):463-70. PubMed ID: 23925919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.
    Patel C; Loughran D; Jones R; Abdulmajed M; Shergill I
    BMC Urol; 2017 Mar; 17(1):16. PubMed ID: 28283031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of ultraflex metallic stents in benign and malignant central airway obstruction.
    Husain SA; Finch D; Ahmed M; Morgan A; Hetzel MR
    Ann Thorac Surg; 2007 Apr; 83(4):1251-6. PubMed ID: 17383321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.
    Miyazaki J; Onozawa M; Takahashi S; Maekawa Y; Yasuda M; Wada K; Maeda Y; Masaki T; Yamaguchi A; Suzuki M; Sakai Y; Kimura T; Takai M; Seike K; Hashimoto T; Yamamoto S
    BMC Urol; 2019 Dec; 19(1):137. PubMed ID: 31881875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.